BlackRock Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$44.9M Sell
1,438,347
-53,217
-4% -$1.72M 0.05% 337
2016
Q3
$59.9M Sell
1,491,564
-131,583
-8% -$4.96M 0.07% 252
2016
Q2
$54M Buy
1,623,147
+24,261
+2% +$830K 0.07% 279
2016
Q1
$47M Sell
1,598,886
-13,161
-0.8% -$363K 0.06% 300
2015
Q4
$42.4M Buy
1,612,047
+15,261
+1% +$396K 0.05% 314
2015
Q3
$37.8M Sell
1,596,786
-36,948
-2% -$892K 0.05% 333
2015
Q2
$38.8M Buy
1,633,734
+140,028
+9% +$3.16M 0.05% 342
2015
Q1
$35.5M Sell
1,493,706
-10,344
-0.7% -$232K 0.05% 363
2014
Q4
$31.9M Sell
1,504,050
-26,796
-2% -$538K 0.04% 394
2014
Q3
$26.1M Buy
1,530,846
+22,218
+1% +$351K 0.04% 438
2014
Q2
$21.6M Buy
1,508,628
+213,228
+16% +$2.89M 0.03% 511
2014
Q1
$16M Sell
1,295,400
-8,346
-0.6% -$96.3K 0.02% 627
2013
Q4
$14.3M Buy
1,303,746
+71,346
+6% +$804K 0.02% 668
2013
Q3
$14.3M Buy
1,232,400
+58,404
+5% +$683K 0.02% 619
2013
Q2
$13.1M Buy
+1,173,996
New +$13.9M 0.02% 607

Other funds holding EW

BlackRock Investment Management's EW Position: Q4 2016 in Review

BlackRock Investment Management reduced its Edwards Lifesciences (EW) stake by 3.6% in Q4 2016, selling an estimated $1.72M and leaving 1,438,347 shares worth $44.9M. The position accounts for 0.05% of the portfolio, ranked #337.

BlackRock Investment Management first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.9M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • BlackRock Investment Management held 1,438,347 shares of Edwards Lifesciences worth $44.9M as of Q4 2016.
  • BlackRock Investment Management sold 53,217 Edwards Lifesciences shares in Q4 2016, an estimated $1.72M.
  • Edwards Lifesciences made up 0.05% of BlackRock Investment Management's portfolio in Q4 2016, its #337 holding.
  • BlackRock Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Edwards Lifesciences position peaked at $59.9M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.